Year archive

Intercure Ltd. — 2023 filings

All 54 regulatory filings released by Intercure Ltd. (INCR) in 2023, sourced directly from the official regulator.

54 Filings

2023 Period

2023 filings (54)

Filing	Released	Lang
6K-Annual General Meeting Results Declaration of Voting Results & Voting Rights Announcements	2023-12-15	English
6K-Annual General Meeting Results Report Publication Announcement	2023-12-15	English
Foreign Filer Report 2023 Foreign Filer Report	2023-12-14	English
ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 Proxy Solicitation & Information Statement	2023-11-09	English
ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 Proxy Solicitation & Information Statement	2023-11-09	English
ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 AGM Information	2023-11-09	English
Foreign Filer Report 2023 Foreign Filer Report	2023-11-08	English
FORM 6-K-InterCure Wins Cannolam Arbitration Proceeding Regulatory Filings	2023-10-31	English
FORM 6-K-InterCure Wins Cannolam Arbitration Proceeding Regulatory Filings	2023-10-31	English
Foreign Filer Report 2023 Foreign Filer Report	2023-10-31	English
InterCure Provides an Update Regarding the Security Situation in Israel Regulatory Filings	2023-10-18	English
InterCure Provides an Update Regarding the Security Situation in Israel Regulatory Filings	2023-10-18	English
Foreign Filer Report 2023 Foreign Filer Report	2023-10-17	English
FINANCIAL STATEMENTS As of June 30, 2023 Earnings Release H1 2023	2023-09-01	English
FINANCIAL STATEMENTS As of June 30, 2023 Report Publication Announcement	2023-09-01	English
Foreign Filer Report 2023 Foreign Filer Report	2023-08-31	English
General Meeting of Shareholders results : delist from trading on the TSX Regulatory Filings	2023-08-15	English
General Meeting of Shareholders results : delist from trading on the TSX Report Publication Announcement	2023-08-15	English
Foreign Filer Report 2023 Foreign Filer Report	2023-08-14	English
SPECIAL MEETING OF SHAREHOLDERS will be held on 14.8.23 Proxy Solicitation & Information Statement	2023-07-25	English
SPECIAL MEETING OF SHAREHOLDERS will be held on 14.8.23 AGM Information	2023-07-25	English
SPECIAL MEETING OF SHAREHOLDERS will be held on 14.8.23 Proxy Solicitation & Information Statement	2023-07-25	English
Foreign Filer Report 2023 Foreign Filer Report	2023-07-24	English
Foreign Filer Report 2023 Foreign Filer Report	2023-07-11	English
Announces Proposed Voluntary Delisting from the Toronto Stock Exchangeand shall continue to be listed on the NASDAQ and TASE Delisting Announcement	2023-07-11	English
Announces Proposed Voluntary Delisting from the Toronto Stock Exchangeand shall continue to be listed on the NASDAQ and TASE Regulatory Filings	2023-07-11	English
Foreign Filer Report 2023 Foreign Filer Report	2023-06-12	English
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merge Legal Proceedings Report	2023-06-10	English
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merge Regulatory Filings	2023-06-10	English
Foreign Filer Report 2023 Foreign Filer Report	2023-05-16	English
First Quarter 2023 Results Earnings Release Q1 2023	2023-05-16	English
First Quarter 2023 Results Report Publication Announcement	2023-05-16	English
Annual Report 2022 Annual Report FY 2022	2023-05-01	English
Foreign Filer Report 2023 Foreign Filer Report	2023-04-26	English
Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary Legal Proceedings Report	2023-04-26	English
Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary Regulatory Filings	2023-04-26	English
Foreign Filer Report 2023 Foreign Filer Report	2023-04-25	English
e Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel Legal Proceedings Report	2023-04-25	English
e Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel Regulatory Filings	2023-04-25	English
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries Regulatory Filings	2023-04-20	English
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries Report Publication Announcement	2023-04-20	English
Foreign Filer Report 2023 Foreign Filer Report	2023-04-20	English
InterCure Announces Reschedules 2022 Full Year Results Conference Call Report Publication Announcement	2023-04-04	English
InterCure Announces Reschedules 2022 Full Year Results Conference Call Report Publication Announcement	2023-04-04	English
Foreign Filer Report 2023 Foreign Filer Report	2023-04-03	English
Foreign Filer Report 2023 Foreign Filer Report	2023-04-03	English
Fourth Quarter and Fiscal Year End 2022 Results Earnings Release FY 2022	2023-04-01	English
Fourth Quarter and Fiscal Year End 2022 Results Report Publication Announcement	2023-04-01	English
Intercure Files Lawsuit Against Cann Pharmacuticals to Recover Funds Following Failed Merger Legal Proceedings Report	2023-02-14	English
Intercure Files Lawsuit Against Cann Pharmacuticals to Recover Funds Following Failed Merger Regulatory Filings	2023-02-14	English
Foreign Filer Report 2023 Foreign Filer Report	2023-02-14	English
Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better) M&A Activity	2023-02-01	English
Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better) Report Publication Announcement	2023-02-01	English
Foreign Filer Report 2023 Foreign Filer Report	2023-02-01	English